Searchable abstracts of presentations at key conferences in endocrinology

ea0066p72 | Pituitary | BSPED2019

Real-world safety data in children with Noonan syndrome treated with growth hormone: results from NordiNet®IOS and the Answer®Program

Juliusson Petur , Dahlgren Jovanna , Abuzzahab Jennifer , Blair Jo , Pietropoli Alberto , Romano Alicia

Objective: To describe real-world safety data on growth hormone therapy (GHT) in paediatric patients with Noonan syndrome (NS) who were enrolled in NordiNet® IOS and the ANSWER®Program.Introduction: Patients with NS have a high prevalence of cardiac defects and an increased risk for leukaemia and certain malignancies compared to the general population. Current safety data do not indicate an association of GHT with worsenin...